Discover
LXRX
Lexicon Pharmaceuticals, Inc.
2.43
4 x 2.35
1 x 2.44
bid
ask
+
0.03
1.25%
100 @ 04:00 PM
2.38 -0.05 (2.06%)
| Ytd | 111.30% | |
| 1y | 133.65% |
2.31
day range
2.43
1.02
52 week range
2.68
| Open | 2.42 | Prev Close | 2.40 | Low | 2.31 | High | 2.43 | Mkt Cap | 1.08B |
| Vol | 0.00 | Avg Vol | 3.28M | EPS | -0.14 | P/E | -17.04 | Forward P/E | -12.79 |
| Beta | 1.03 | Short Ratio | 6.92 | Inst. Own | 82.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.21 | 200-d Avg | 1.70 | 1yr Est | 3.86 |
| Income Statement | |||
| Total Revenue | 692.00K | ||
| Revenues (USD) | 692.00K | ||
| Cost of Revenue | 39.00K | ||
| Gross Profit | 653.00K | ||
| Operating Expenses | 27.19M | ||
| Research and Development Expense | 17.44M | ||
| Selling, General and Administrative Expense | 9.75M | ||
| Operating Income | -26.54M | ||
| Interest Expense | 2.61M | ||
| Net Income | -31.77M | ||
| Net Income Common Stock | -31.77M | ||
| Net Income Common Stock (USD) | -31.77M | ||
| Consolidated Income | -31.77M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -29.17M | ||
| Earning Before Interest & Taxes (USD) | -29.17M | ||
| Weighted Average Shares | 437.65M | ||
| Weighted Average Shares Diluted | 437.65M | ||
| Balance Sheet | |||
| Cash and Equivalents | 40.92M | ||
| Cash and Equivalents (USD) | 40.92M | ||
| Investments | 149.69M | ||
| Investments Current | 149.69M | ||
| Trade and Non-Trade Receivables | 1.64M | ||
| Current Assets | 196.58M | ||
| Property, Plant & Equipment Net | 8.57M | ||
| Total Assets | 250.06M | ||
| Total Debt | 51.44M | ||
| Current Liabilities | 14.71M | ||
| Debt Non-Current | 51.44M | ||
| Total Liabilities | 75.54M | ||
| Accumulated Retained Earnings (Deficit) | -2.05B | ||
| Accumulated Other Comprehensive Income | -204.00K | ||
| Shareholders Equity | 174.53M | ||
| Shareholders Equity (USD) | 174.53M | ||
| Assets Non-Current | 53.48M | ||
| Total Debt (USD) | 51.44M | ||
| Goodwill and Intangible Assets | 44.54M | ||
| Inventory | 1.20M | ||
| Liabilities Non-Current | 60.83M | ||
| Trade and Non-Trade Payables | 2.34M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 102.00K | ||
| Net Cash Flow from Financing | -512.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -26.16M | ||
| Issuance (Purchase) of Equity Shares | 1.02M | ||
| Issuance (Repayment) of Debt Securities | 739.00K | ||
| Net Cash Flow from Investing | -16.46M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -16.46M | ||
| Net Cash Flow from Operations | -9.19M | ||
| Share Based Compensation | 3.34M | ||